Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503386
Status:
COMPLETED
Last Update Posted:
2010-09-17
First Post:
2007-07-16
Brief Title:
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting
Sponsor:
Hangzhou Jiuyuan Gene Engineering Co Ltd
Organization:
Hangzhou Jiuyuan Gene Engineering Co Ltd
Study Overview
Official Title:
A Phase IIMulticenterRandomizedDouble-blindCross-over Study of Palonosetron Compared With Granisetron in Prevention of Chemotherapy-induced Nausea and Vomiting in Asian Population
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether palonosetron is tolerate and effective in preventing chemotherapy-induced nausea and vomiting in oriental population The study is comparing the safety and efficacy of palonosetron with granisetron a frequently used antiemetic in China
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None